These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14981341)

  • 1. Augmentation of the development of behavioral tolerance to cannabinoid administration through pavlovian conditioning.
    Hill MN; Gorzalka BB; Choi JW
    Neuropsychobiology; 2004; 49(2):94-100. PubMed ID: 14981341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
    Caberlotto L; Rimondini R; Hansson A; Eriksson S; Heilig M
    Neuropsychopharmacology; 2004 Jan; 29(1):15-22. PubMed ID: 12968131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.
    Bosier B; Sarre S; Smolders I; Michotte Y; Hermans E; Lambert DM
    Neuropharmacology; 2010 Nov; 59(6):503-10. PubMed ID: 20633567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats.
    Moreno M; Lopez-Moreno JA; Rodríguez de Fonseca F; Navarro M
    Behav Pharmacol; 2005 Sep; 16(5-6):441-6. PubMed ID: 16148449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat.
    Ferrari F; Ottani A; Giuliani D
    Life Sci; 1999; 65(8):823-31. PubMed ID: 10466748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.
    del Arco I; Muñoz R; Rodríguez De Fonseca F; Escudero L; Martín-Calderón JL; Navarro M; Villanúa MA
    Neuroimmunomodulation; 2000; 7(1):16-26. PubMed ID: 10601815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.
    Boucher AA; Hunt GE; Micheau J; Huang X; McGregor IS; Karl T; Arnold JC
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):631-43. PubMed ID: 20701826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models.
    Ottani A; Ferrari F; Giuliani D
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):91-6. PubMed ID: 11853125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in antinociceptive and motoric effects of cannabinoids.
    Tseng AH; Craft RM
    Eur J Pharmacol; 2001 Oct; 430(1):41-7. PubMed ID: 11698061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.
    Aracil-Fernández A; Almela P; Manzanares J
    Addict Biol; 2013 Mar; 18(2):252-62. PubMed ID: 22017514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits.
    Naveh N; Weissman C; Muchtar S; Benita S; Mechoulam R
    Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):334-8. PubMed ID: 10853933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.
    Giuliani D; Ferrari F; Ottani A
    Pharmacol Res; 2000 Jan; 41(1):47-53. PubMed ID: 10600269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210.
    Leker RR; Gai N; Mechoulam R; Ovadia H
    Stroke; 2003 Aug; 34(8):2000-6. PubMed ID: 12829867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeostatic regulation and Pavlovian conditioning in tolerance to amphetamine-induced anorexia.
    Poulos CX; Wilkinson DA; Cappell H
    J Comp Physiol Psychol; 1981 Oct; 95(5):735-46. PubMed ID: 7309926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo.
    Hill MN; Froc DJ; Fox CJ; Gorzalka BB; Christie BR
    Eur J Neurosci; 2004 Aug; 20(3):859-63. PubMed ID: 15255998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hu 210: a potent tool for investigations of the cannabinoid system.
    Ottani A; Giuliani D
    CNS Drug Rev; 2001; 7(2):131-45. PubMed ID: 11474421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure.
    Hill MN; Gorzalka BB
    Psychoneuroendocrinology; 2006 May; 31(4):526-36. PubMed ID: 16442741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.